# Anavex Life Sciences Corp.: filings

AVXL · Nasdaq · CIK 1314052 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/avxl.md) · [Financials](/companies/avxl/financials.md) · [Filings](/companies/avxl/filings.md) · [Insiders](/companies/avxl/insiders.md)

## Reports and events: 223 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 156, 8-K 117, 10-Q 54, 10-K 18, 3 16, DEFA14A 16, DEF 14A 14, UPLOAD 14, 424B5 11, DFAN14A 11, EFFECT 11, CORRESP 10, NT 10-Q 10, SC 13G/A 10, 424B3 7, 8-K/A 6, SC 13G 6, S-3 5, 10-K/A 4, ARS 4, D 4, PRE 14A 4, S-1 4, S-3/A 4, POS AM 3, S-1/A 3, S-8 3, 10-Q/A 2, 144 2, DEFC14A 2, PREC14A 2, PRRN14A 2, 4/A 1, 5 1, 8-A12B 1, AW 1, CERTNAS 1, CT ORDER 1, S-3ASR 1, SC 13D/A 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:16 ET | [8-K](/filings/0001731122-26-001351.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001351 |
| 2026-10-15 | 20:18 ET | [8-K](/filings/0001731122-26-001348.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001348 |
| 2026-09-28 | 21:27 ET | [8-K](/filings/0001731122-26-001294.md) | 5.01 Change in control; 5.07 Shareholder vote results | 0001731122-26-001294 |
| 2026-09-09 | 21:17 ET | [8-K](/filings/0001731122-26-001211.md) | 8.01 Other events | 0001731122-26-001211 |
| 2026-09-02 | 21:06 ET | [8-K](/filings/0001731122-26-001179.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001179 |
| 2026-08-28 | 20:28 ET | [10-Q](/filings/0001731122-26-001167.md) | Quarterly report, period 2026-06-30 | 0001731122-26-001167 |
| 2026-08-28 | 20:26 ET | [10-Q](/filings/0001731122-26-001166.md) | Quarterly report, period 2026-03-31 | 0001731122-26-001166 |
| 2026-08-28 | 20:25 ET | [10-Q/A](/filings/0001731122-26-001165.md) | Quarterly report, amended, period 2025-12-31 | 0001731122-26-001165 |
| 2026-08-28 | 20:24 ET | [10-K/A](/filings/0001731122-26-001164.md) | Annual report, amended, period 2025-09-30 | 0001731122-26-001164 |
| 2026-08-25 | 12:31 ET | [8-K](/filings/0001731122-26-001143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001731122-26-001143 |
| 2026-08-17 | 12:10 ET | [8-K](/filings/0001731122-26-001078.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001078 |
| 2026-08-11 | 21:00 ET | [8-K](/filings/0001731122-26-001042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001042 |
| 2026-08-03 | 12:26 ET | [8-K](/filings/0001731122-26-001000.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001000 |
| 2026-07-30 | 12:15 ET | [8-K](/filings/0001731122-26-000988.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001731122-26-000988 |
| 2026-07-20 | 12:59 ET | [8-K](/filings/0001731122-26-000957.md) | 8.01 Other events | 0001731122-26-000957 |
| 2026-06-26 | 10:15 ET | [8-K](/filings/0001731122-26-000889.md) | 8.01 Other events | 0001731122-26-000889 |
| 2026-05-22 | 12:15 ET | [8-K](/filings/0001731122-26-000781.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000781 |
| 2026-05-15 | 20:15 ET | [8-K](/filings/0001731122-26-000744.md) | 5.02 Departure or appointment of officers or directors | 0001731122-26-000744 |
| 2026-05-06 | 11:04 ET | [8-K](/filings/0001731122-26-000678.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001731122-26-000678 |
| 2026-03-25 | 20:06 ET | [8-K](/filings/0001731122-26-000482.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000482 |
| 2026-02-25 | 11:07 ET | [8-K](/filings/0001731122-26-000305.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000305 |
| 2026-02-09 | 21:40 ET | [10-Q](/filings/0001731122-26-000200.md) | Quarterly report, period 2025-12-31 | 0001731122-26-000200 |
| 2026-02-09 | 12:31 ET | [8-K](/filings/0001731122-26-000193.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001731122-26-000193 |
| 2025-11-25 | 21:31 ET | [10-K](/filings/0001731122-25-001596.md) | Annual report, period 2025-09-30 | 0001731122-25-001596 |
| 2025-11-25 | 12:30 ET | [8-K](/filings/0001731122-25-001591.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001731122-25-001591 |
| 2025-11-14 | 12:42 ET | [8-K](/filings/0001731122-25-001536.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-25-001536 |
| 2025-08-12 | 20:08 ET | [10-Q](/filings/0001731122-25-001105.md) | Quarterly report, period 2025-06-30 | 0001731122-25-001105 |
| 2025-07-28 | 23:26 ET | [8-K](/filings/0001731122-25-001033.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-25-001033 |
| 2025-07-03 | 21:25 ET | [8-K](/filings/0001731122-25-000935.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001731122-25-000935 |
| 2025-06-13 | 21:30 ET | [8-K](/filings/0001731122-25-000878.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001731122-25-000878 |
| 2025-05-13 | 20:31 ET | [10-Q](/filings/0001731122-25-000724.md) | Quarterly report, period 2025-03-31 | 0001731122-25-000724 |
| 2025-04-25 | 20:31 ET | [DEF 14A](/filings/0001731122-25-000607.md) | Proxy statement, period 2025-04-25 | 0001731122-25-000607 |
| 2025-02-12 | 14:06 ET | [10-Q](/filings/0001731122-25-000205.md) | Quarterly report, period 2024-12-31 | 0001731122-25-000205 |
| 2024-12-23 | 21:30 ET | [10-K](/filings/0001731122-24-002041.md) | Annual report, period 2024-09-30 | 0001731122-24-002041 |
| 2024-08-06 | 21:21 ET | [10-Q](/filings/0001731122-24-001207.md) | Quarterly report, period 2024-06-30 | 0001731122-24-001207 |
| 2024-07-30 | 21:20 ET | [8-K](/filings/0001731122-24-001160.md) | 1.02 Termination of a material agreement | 0001731122-24-001160 |
| 2024-06-21 | 20:30 ET | [8-K](/filings/0001731122-24-001003.md) | 5.07 Shareholder vote results | 0001731122-24-001003 |
| 2024-05-09 | 20:35 ET | [10-Q](/filings/0001731122-24-000760.md) | Quarterly report, period 2024-03-31 | 0001731122-24-000760 |
| 2024-05-09 | 12:00 ET | [8-K](/filings/0001731122-24-000758.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001731122-24-000758 |
| 2024-05-06 | 10:01 ET | [DEF 14A](/filings/0001731122-24-000730.md) | Proxy statement, period 2024-05-06 | 0001731122-24-000730 |
| 2024-02-07 | 21:31 ET | [10-Q](/filings/0001731122-24-000206.md) | Quarterly report, period 2023-12-31 | 0001731122-24-000206 |
| 2023-11-27 | 21:30 ET | [10-K](/filings/0001731122-23-002197.md) | Annual report, period 2023-09-30 | 0001731122-23-002197 |
| 2023-08-08 | 20:30 ET | [10-Q](/filings/0001731122-23-001412.md) | Quarterly report, period 2023-06-30 | 0001731122-23-001412 |
| 2023-05-24 | 20:30 ET | [8-K](/filings/0001731122-23-001007.md) | 5.07 Shareholder vote results | 0001731122-23-001007 |
| 2023-05-09 | 20:31 ET | [10-Q](/filings/0001731122-23-000845.md) | Quarterly report, period 2023-03-31 | 0001731122-23-000845 |
| 2023-04-14 | 10:01 ET | [8-K](/filings/0001731122-23-000651.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-23-000651 |
| 2023-04-04 | 20:33 ET | [DEF 14A](/filings/0001731122-23-000573.md) | Proxy statement, period 2023-04-04 | 0001731122-23-000573 |
| 2023-03-13 | 23:32 ET | [8-K](/filings/0001731122-23-000348.md) | 7.01 Regulation FD disclosure | 0001731122-23-000348 |
| 2023-02-07 | 22:20 ET | [8-K](/filings/0001731122-23-000156.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-23-000156 |
| 2023-02-07 | 22:11 ET | [10-Q](/filings/0001731122-23-000152.md) | Quarterly report, period 2022-12-31 | 0001731122-23-000152 |

Page 1 of 5. [Older](/companies/avxl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.